Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malaria prevention in pregnancy in Tanzania
PACTR201612001901313Completed
- Sponsor
- Muhimbili University of Health and Allied Sciences
- Start
- Jan 2017
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of dihydroartemisinin, piperaquine, sulfadoxine, pyrimethamine and trimethoprim + sulfamethoxazole in malaria (4 arms), sponsored by Muhimbili University of Health and Allied Sciences. Primary endpoint: Active or recent placental malaria. Started Jan 2017; status: completed.
02
Drugs
dihydroartemisininpiperaquinesulfadoxinepyrimethaminetrimethoprim + sulfamethoxazole
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201612001901313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201612001901313.